Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • Aarti Pharmalabs
Join Channel
Consolidated Standalone

Aarti Pharmalabs

₹498.4 3.2 | 0.6%

Market Cap ₹4516 Cr.

Stock P/E 23.2

P/B 2.6

Current Price ₹498.4

Book Value ₹ 188.7

Face Value 5

52W High ₹594.9

Dividend Yield 0.4%

52W Low ₹ 320.3

Edit Ratio

Aarti Pharmalabs Research see more...

Overview Inc. Year: 2019Industry: Pharmaceuticals & Drugs

Aarti Pharmalabs Ltd is a leading Indian pharmaceutical company that specializes in manufacturing and exporting high-quality active pharmaceutical ingredients (APIs) and intermediates. Founded in 1984, the company has a diverse product portfolio that includes antibiotics, anti-inflammatory drugs, anti-cancer agents, and cardiovascular drugs, among others. Aarti Pharmalabs operates a state-of-the-art manufacturing facility that adheres to international quality standards and employs cutting-edge technology to ensure product excellence and customer satisfaction. The company has a global presence and exports to over 60 countries, including the United States, Europe, and Asia. With a focus on research and development, Aarti Pharmalabs is committed to delivering innovative solutions to improve healthcare worldwide.

Read More..

Aarti Pharmalabs Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Aarti Pharmalabs Quarterly Results

#(Fig in Cr.) Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 460 457 531 472 485 458 440 449
Other Income 3 0 1 0 1 0 1 1
Total Income 463 457 532 472 486 459 441 450
Total Expenditure 385 371 441 385 405 373 352 353
Operating Profit 78 86 91 87 81 85 89 97
Interest 5 4 6 5 6 4 4 4
Depreciation 14 14 17 16 16 17 18 19
Exceptional Income / Expenses 0 0 0 0 0 0 0 0
Profit Before Tax 59 68 69 65 59 64 67 74
Provision for Tax 11 16 18 17 16 17 15 21
Profit After Tax 49 52 51 48 43 47 52 53
Adjustments 0 0 0 0 0 0 0 0
Profit After Adjustments 49 52 51 48 43 47 52 53
Adjusted Earnings Per Share 5.4 5.7 5.6 5.3 4.7 5.2 5.7 5.8

Aarti Pharmalabs Profit & Loss

#(Fig in Cr.) Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 0 1200 1945 1832
Other Income 0 4 2 3
Total Income 0 1204 1948 1836
Total Expenditure 0 995 1603 1483
Operating Profit -0 209 344 352
Interest 0 12 21 18
Depreciation 0 42 63 70
Exceptional Income / Expenses 0 0 0 0
Profit Before Tax -0 155 261 264
Provision for Tax 0 33 67 69
Profit After Tax -0 122 193 195
Adjustments 0 0 0 0
Profit After Adjustments -0 122 193 195
Adjusted Earnings Per Share -0.2 4890 21.4 21.4

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 62% 0% 0% 0%
Operating Profit CAGR 65% 0% 0% 0%
PAT CAGR 58% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 30% NA% NA% NA%
ROE Average 13% 10% 10% 10%
ROCE Average 16% 11% 11% 11%

Aarti Pharmalabs Balance Sheet

#(Fig in Cr.) Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 0 1386 1558
Minority's Interest 0 0 0
Borrowings 0 1 0
Other Non-Current Liabilities 0 72 81
Total Current Liabilities 0 581 592
Total Liabilities 0 2040 2231
Fixed Assets 0 782 926
Other Non-Current Assets 0 230 149
Total Current Assets 0 1028 1156
Total Assets 0 2040 2231

Aarti Pharmalabs Cash Flow

#(Fig in Cr.) Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 0 5 83
Cash Flow from Operating Activities 0 -44 263
Cash Flow from Investing Activities 0 -139 -158
Cash Flow from Financing Activities 0 260 -163
Net Cash Inflow / Outflow 0 78 -58
Closing Cash & Cash Equivalent 0 83 25

Aarti Pharmalabs Ratios

# Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) -0.18 4890.04 21.35
CEPS(Rs) -0.18 6574.79 28.25
DPS(Rs) 0 0 2
Book NAV/Share(Rs) 9.12 53646.6 171.97
Core EBITDA Margin(%) 0 17.11 17.58
EBIT Margin(%) 0 13.95 14.49
Pre Tax Margin(%) 0 12.95 13.41
PAT Margin (%) 0 10.19 9.95
Cash Profit Margin (%) 0 13.7 13.16
ROA(%) -1.84 11.98 9.06
ROE(%) -2.02 18.23 13.35
ROCE(%) -1.87 19.4 16.11
Receivable days 0 114.57 76.62
Inventory Days 0 144.62 101.09
Payable days 0 61.41 100.85
PER(x) 0 0 12.86
Price/Book(x) 0 0 1.6
Dividend Yield(%) 0 0 0.73
EV/Net Sales(x) 0 0.21 1.38
EV/Core EBITDA(x) -3.76 1.22 7.78
Net Sales Growth(%) 0 0 62.11
EBIT Growth(%) 0 0 68.42
PAT Growth(%) 0 0 58.28
EPS Growth(%) 0 0 -99.56
Debt/Equity(x) 0.08 0.25 0.14
Current Ratio(x) 11.42 1.77 1.95
Quick Ratio(x) 11.42 0.95 0.94
Interest Cover(x) 0 13.99 13.39
Total Debt/Mcap(x) 0 0 0.09

Aarti Pharmalabs Shareholding Pattern

# Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 45.98 45.98 46.3 46.46 46.46
FII 7.69 7.43 8.45 8.16 8.32
DII 13.69 10.66 10.52 9.92 9.98
Public 32.64 35.93 34.73 35.46 35.23
Others 0 0 0 0 0
Total 100 100 100 100 100

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Promoter holding is low: 46.46%.
  • Company has a low return on equity of 10% over the last 3 years.
  • Debtor days have increased from 61.41 to 100.85days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Aarti Pharmalabs News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!